Volume 6 Issue 5, May 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 5, May 2021:
Research Highlight
Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
Chenyue Zhang &Haiyong Wang